Pennington, NJ, United States of America

Parviz Gharagozloo

This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Euro-Celtique S.a., Purdue Pharma L.p., Other. Active years: 2003-2018.

USPTO Granted Patents = 7 (Patent Applications = 2)

% Patents Active = 85.7

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 91(Granted Patents)

Location History:

Pennington, PA (US) (2003)
Pennington, NJ (US) (2005 - 2018)

Company Filing History:

2 out of 834,411

Other

patents

Years Active: 2003-2018

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9943543 - Treating male infertility secondary to sperm oxidative stress (2018-04-17),

2. 8377454 - Treating male infertility secondary to sperm oxidative stress (2013-02-19),

3. 7563809 - Nociceptin analogs (2009-07-21),

4. 7169782 - Aryl substituted thiazolidinones and the use thereof (2007-01-30),

5. 6864261 - Therapeutic agents useful for treating pain (2005-03-08),

6. 6861421 - Nociceptin analogs (2005-03-01),

7. 6635653 - Spiropyrazole compounds (2003-10-21),

Title: Parviz Gharagozloo: Innovator in Male Infertility Treatments

Introduction

Parviz Gharagozloo is a notable inventor based in Pennington, NJ (US). He has made significant contributions to the field of male infertility, holding a total of 7 patents. His work focuses on innovative solutions to address sperm oxidative stress, a common issue affecting male fertility.

Latest Patents

One of Gharagozloo's latest patents involves a profertility composition designed for administration to infertile men suffering from sperm oxidative stress. This composition features a unique combination of essential nutrients, including a pharmaceutically acceptable vitamin E, vitamin C, selenium, zinc, folic acid, lycopene, and at least one carnitine source. This innovative approach aims to improve fertility outcomes for men facing these challenges.

Career Highlights

Throughout his career, Gharagozloo has worked with various organizations, including Euro-Celtique S.A. His expertise in the field has led to the development of groundbreaking treatments that have the potential to change the lives of many men struggling with infertility.

Collaborations

Gharagozloo has collaborated with notable professionals in his field, including Donald Kyle and R Richard Goehring. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Parviz Gharagozloo's innovative work in treating male infertility through his patented compositions highlights his commitment to improving reproductive health. His contributions to the field are invaluable and continue to pave the way for future advancements in male fertility treatments.